Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

        Selected Amendments to the FD&C Act

21st Century Cures Act

                        
                21st Century Cures Act Deliverables Home
          Regulatory Information
          Laws Enforced by FDA
          Selected Amendments to the FD&C Act
          21st Century Cures ActSelected Amendments to the FD&C Act 21st Century Cures Act
  	
        Share
    Post
    Linkedin

    Email
    Printimages of FDA-regulated innovative products

The 21st Century Cures Act (Cures Act), signed into law on December 13, 2016, is designed to help accelerate medical product development and bring new innovations and advances to patients who need them faster and more efficiently.

The law builds on FDA's ongoing work to incorporate the perspectives of patients into the development of drugs, biological products, and devices in FDA's decision-making process. Cures enhances our ability to modernize clinical trial designs, including the use of real-world evidence, and clinical outcome assessments, which will speed the development and review of novel medical products, including medical countermeasures.

It also provides new authority to help FDA improve our ability to recruit and retain scientific, technical, and professional experts and it establishes new expedited product development programs, including:

The Regenerative Medicine Advanced Therapy, or RMAT, that offers a new expedited option for certain eligible biologics products.
	The Breakthrough Devices program, designed to speed the review of certain innovative medical devices.In addition, the Cures Act directs FDA to create one or more intercenter institutes to help coordinate  activities in major disease areas between the drug, biologics and device centers and improves the regulation of combination products.

About the Oncology Center of ExcellenceImplementation

FDA is working hard to maximize the authorities and resources Congress granted us in Cures, as FDA Commissioner Scott Gottlieb outlined in an FDA Voice Blog.

Blog: How FDA Plans to Help Consumers Capitalize on Advances in ScienceWork Plan

The Cures Act authorized $500 million over 9 years to help FDA cover the cost of implementing the law.  We developed a draft work plan showing how FDA would use that funding, subject to annual appropriations. In keeping with the statutory requirements, we submitted the draft work plan to FDA’s Science Board for their comments and recommendations at a public meeting in May. The final work plan, which includes the recommendations from the Science Board, was delivered to Congress on June 9.

Submission to Congress: Food & Drug Administration Work Plan and Proposed Funding Allocations of FDA Innovation Account (PDF - 233KB)*Required by Section 1002 of the 21st Century Cures Act (Public Law 114-255)*Resources For You

21st Century Cures Act (Congress.gov)
	Technical Corrections include also in FDA Reauthorization Act of 2017 (FDARA) (Congress.gov)

                                                                                  Content current as of:
      01/31/202021st Century Cures Act                
                          

                        21st Century Cures Act Deliverables
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop